ACUT
Price
$1.50
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
24.11M
APVO
Price
$1.50
Change
-$0.10 (-6.25%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
4.93M
Interact to see
Advertisement

ACUT vs APVO

Header iconACUT vs APVO Comparison
Open Charts ACUT vs APVOBanner chart's image
Accustem Sciences
Price$1.50
Change-$0.00 (-0.00%)
Volume$652
Capitalization24.11M
Aptevo Therapeutics
Price$1.50
Change-$0.10 (-6.25%)
Volume$27.9K
Capitalization4.93M
ACUT vs APVO Comparison Chart in %
Loading...
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACUT vs. APVO commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACUT is a Hold and APVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ACUT: $1.50 vs. APVO: $1.50)
Brand notoriety: ACUT and APVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACUT: 12% vs. APVO: 25%
Market capitalization -- ACUT: $24.11M vs. APVO: $5.26M
ACUT [@Biotechnology] is valued at $24.11M. APVO’s [@Biotechnology] market capitalization is $5.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACUT’s FA Score shows that 1 FA rating(s) are green whileAPVO’s FA Score has 1 green FA rating(s).

  • ACUT’s FA Score: 1 green, 4 red.
  • APVO’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACUT and APVO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACUT’s TA Score shows that 4 TA indicator(s) are bullish while APVO’s TA Score has 3 bullish TA indicator(s).

  • ACUT’s TA Score: 4 bullish, 5 bearish.
  • APVO’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, APVO is a better buy in the short-term than ACUT.

Price Growth

ACUT (@Biotechnology) experienced а +8.70% price change this week, while APVO (@Biotechnology) price change was -14.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACUT($24.1M) has a higher market cap than APVO($4.93M). ACUT YTD gains are higher at: 234.821 vs. APVO (-98.260). ACUT has higher annual earnings (EBITDA): -1.54M vs. APVO (-24.04M). APVO has more cash in the bank: 9.41M vs. ACUT (31.3K). ACUT has less debt than APVO: ACUT (66.4K) vs APVO (4.21M). ACUT (0) and APVO (0) have equivalent revenues.
ACUTAPVOACUT / APVO
Capitalization24.1M4.93M489%
EBITDA-1.54M-24.04M6%
Gain YTD234.821-98.260-239%
P/E RatioN/A0.00-
Revenue00-
Total Cash31.3K9.41M0%
Total Debt66.4K4.21M2%
FUNDAMENTALS RATINGS
APVO: Fundamental Ratings
APVO
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
49
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACUTAPVO
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 18 days ago
79%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ETTYF26.02N/A
N/A
Essity Aktiebolag Publ
QZMRF0.60N/A
N/A
Quartz Mountain Resources Ltd.
IQAIF0.02N/A
N/A
Imaging Biometrics Ltd
ASPHF9.32N/A
N/A
ASCENTAGE PHARMA GROUP
WCCB42.49N/A
N/A
West Coast Community Bancorp

ACUT and

Correlation & Price change

A.I.dvisor tells us that ACUT and LGVN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACUT and LGVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACUT
1D Price
Change %
ACUT100%
N/A
LGVN - ACUT
30%
Poorly correlated
+0.44%
OKYO - ACUT
28%
Poorly correlated
-4.50%
APVO - ACUT
20%
Poorly correlated
-6.25%
VRNA - ACUT
20%
Poorly correlated
N/A
CLRPF - ACUT
9%
Poorly correlated
N/A
More

APVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, APVO has been loosely correlated with ENLV. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APVO jumps, then ENLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APVO
1D Price
Change %
APVO100%
-6.25%
ENLV - APVO
36%
Loosely correlated
-0.49%
KROS - APVO
34%
Loosely correlated
+1.46%
GNPX - APVO
33%
Loosely correlated
-3.48%
IMRX - APVO
29%
Poorly correlated
+0.80%
INO - APVO
28%
Poorly correlated
+1.69%
More